The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • Gene obtained from curated document aligns with the Allele Registry but not with ClinVar data
  • No CSPEC computed assertion could be determined for this classification!


Variant: NM_001306179.2:c.319C>A

CA386954869

1327593 (ClinVar)

Gene: HNF1A
Condition: monogenic diabetes
Inheritance Mode: Autosomal dominant inheritance
UUID: cc023e7f-ba48-4897-be35-7dde62a32b0b
Approved on: 2025-07-16
Published on: 2025-07-25

HGVS expressions

NM_001306179.2:c.319C>A
NC_000012.12:g.120979087C>A
CM000674.2:g.120979087C>A
NC_000012.11:g.121416890C>A
CM000674.1:g.121416890C>A
NC_000012.10:g.119901273C>A
NG_011731.2:g.5342C>A
ENST00000560968.6:c.319C>A
ENST00000257555.11:c.319C>A
ENST00000257555.10:c.319C>A
ENST00000400024.6:c.319C>A
ENST00000402929.5:n.454C>A
ENST00000535955.5:n.42+395C>A
ENST00000538626.2:n.190+247C>A
ENST00000538646.5:c.319C>A
ENST00000540108.1:c.319C>A
ENST00000541395.5:c.319C>A
ENST00000541924.5:c.319C>A
ENST00000543427.5:c.319C>A
ENST00000544413.2:c.319C>A
ENST00000544574.5:c.72+247C>A
ENST00000560968.5:c.462C>A
ENST00000615446.4:c.-258+376C>A
ENST00000617366.4:c.319C>A
NM_000545.5:c.319C>A
NM_000545.6:c.319C>A
NM_001306179.1:c.319C>A
NM_000545.8:c.319C>A
More

Pathogenic

Met criteria codes 6
PP3 PM2_Supporting PS3_Supporting PM1_Supporting PP4_Moderate PP1_Strong
Not Met criteria codes 1
PS4

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Monogenic Diabetes Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for HNF1A Version 3.0.0

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Monogenic Diabetes VCEP
The c.319C>A variant in the HNF1 homeobox A gene, HNF1A, causes an amino acid change of leucine to isoleucine at codon 107 (p.(Leu107Ile)) of NM_000545.8. This variant is located within the DNA binding domain (codons 107-174) of HNF1A, which is defined as critical for the protein’s function by the ClinGen MDEP (PM1_Supporting), and is predicted to be deleterious by computational evidence, with a REVEL score of 0.7509, which is greater than the MDEP threshold of 0.70 (PP3). Functional studies have also demonstrated the p.Leu107Ile protein has DNA binding below 40% of wild type, indicating that this variant impacts protein function (PMID:12488960). This variant is absent from gnomAD v4.1.0 (PM2_Supporting). This variant was identified in two unrelated individuals with non-autoimmune and non-absolute/near-absolute insulin-deficient diabetes; however, PS4_Moderate cannot be applied because this number is below the ClinGen MDEP threshold (PMID: 10447526, internal lab contributors). One of these individuals did have a clinical history highly specific for HNF1A-monogenic diabetes (MODY probability calculator result >50%, negative genetic testing for HNF4A, and negative antibody) (PP4_Moderate; internal lab contributors). Additionally, this variant segregated with diabetes with eight informative meioses in one family (PP1_Strong; PMID:10447526). Taken together, this evidence supports the classification of c.319C>A as pathogenic for monogenic diabetes. ACMG/AMP criteria applied, as specified by the ClinGen MDEP VCEP (specification version 3.0.0, approved 8/11/2023): PP1_Strong, PP4_Moderate, PP3, PM1_Supporting, PM2_Supporting, PS3_Supporting.
Met criteria codes
PP3
This variant is predicted to be deleterious by computational evidence, with a REVEL score of 0.7509, which is greater than the MDEP threshold of 0.70 (PP3).
PM2_Supporting
This variant is absent from gnomAD v4.1.0 (PM2_Supporting).
PS3_Supporting
Functional studies demonstrated the p.Leu107Ile protein has DNA binding below 40% of wild type, indicating that this variant impacts protein function (PMID:12488960) .
PM1_Supporting
This variant is located within the DNA binding domain (codons 107-174) of HNF1A, which is defined as critical for the protein’s function by the ClinGen MDEP (PM1_Supporting).
PP4_Moderate
This variant was identified in an individual with a clinical history highly specific for HNF1A-monogenic diabetes (MODY probability calculator result >50%, negative genetic testing for HNF4A, and negative autoantibodies) (PP4_Moderate; internal lab contributors).
PP1_Strong
This variant segregated with diabetes, with eight informative meioses in one family (PP1_Strong; PMID:10447526)
Not Met criteria codes
PS4
This variant was identified in two unrelated individuals with non-autoimmune and non-absolute/near-absolute insulin-deficient diabetes; however, PS4_Moderate cannot be applied because this number is below the ClinGen MDEP threshold (PMID: 10447526, internal lab contributors).
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.